Global Biotech Corp. Launches New Product Line QB-1:

/ Source: GlobeNewswire

WILMINGTON, Del., Oct. 12, 2010 (GLOBE NEWSWIRE) -- Global Biotech Corp. (OTCQB:GBIQ) and (CNSX:GBQ) is a publicly traded company with interests in the nutraceutical, cosmeceutical, pharmaceutical and phytochemical areas. Global owns the trademarked product Aquaboost, oxygenated spring water and now Quantum Boost (QB).

As of October 12, 2010, we have finished the formulation of our unique oxygenated drinks that will address the well-being of our clientele as an exciting alternative to other beverages currently on the market. The new trademark will be Quantum Boost (QB) and will contain proprietary formulations to take a defensive look to establishing good health. 

About: Global Biotech Corp. is dedicated to investigating and developing natural products to curb the negative impact on our environment. Global is positioning its AquaBoost (TM) product as a top quality oxygenated water due to its unique oxygenation level (up to 100 ppm and greater), ability to retain this level of oxygenation over lengthy periods of time and the purity of the product. The Company is also in the process of exploring other naturally oxygenated beverages and is involved in the development of several pharmaceutical and cosmeceutical products.

Forward-Looking Statements

This press release may contain forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering into new business, anticipated sources of funds, including the proceeds from future operations, and plans, objectives, expectations and intentions contained in this Press Release that are not historical facts. When used in this Press Release, the words "expects," "intends," "projects," "plans," "believes," "seeks," "estimates" and similar expressions are generally intended to identify forward-looking statements. Because these forward-looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release. These risks are outlined in our SEC and SEDAR filings.

CONTACT: Global Biotech Corp. Louis Greco, President (613) 269-3030